Vivan Therapeutics

The company's flagship service, the Personal Discovery Process (PDP), involves creating a highly detailed genetic model of a patient's tumor using 400,000 fruit fly avatars. These avatars are then subjected to a wide array of FDA-approved drugs, including those not traditionally used for cancer treatment. This large-scale testing helps identify the most effective drug combinations tailored to the patient's specific cancer profile.

Vivan Therapeutics primarily serves cancer patients who are seeking personalized treatment options, as well as healthcare providers looking for advanced therapeutic recommendations for their patients. The company operates in the oncology market, which focuses on the diagnosis and treatment of cancer.

The business model of Vivan Therapeutics revolves around offering personalized treatment plans based on extensive research and testing. They generate revenue by charging for their PDP service, which provides detailed and customized treatment recommendations. This service is particularly valuable for patients whose treatment options may be limited or who have not responded well to standard therapies.

In summary, Vivan Therapeutics stands out in the oncology field by offering a highly personalized approach to cancer treatment, utilizing innovative genetic and robotic technologies to improve patient outcomes.